Cerebral stroke thrombolysis patient evaluation method, device and equipment and storage medium

Abstract

The invention discloses a cerebral apoplexy thrombolysis patient evaluation method, device and equipment and a storage medium, and the evaluation method comprises the steps: obtaining patient information, obtaining the weight data of a patient from a record database, reading the type of a drug, obtaining a dose coefficient and a conversion factor from a drug database, dose data of the thrombolytic drug is calculated through a first formula and is sent to the display module to be displayed, rapid conversion of the administration dose is achieved, calculation errors of the thrombolytic drug dose are avoided, then blood pressure data, heart rate data and blood oxygen saturation data of a patient are obtained in real time, and the accuracy of thrombolytic drug dose calculation is improved. And judging whether the vital signs are correspondingly located in the first range, the second range and the third range or not, and if not, sending out an alarm signal, so as to accurately judge the vital sign data of the thrombolysis patient, timely discover abnormity and send out an early warning.

Description

Technical Field

[0001] This invention relates to the field of patient assessment technology, and in particular to a method, apparatus, device, and storage medium for assessing stroke patients undergoing thrombolysis. Background Technology

[0002] Stroke is characterized by high morbidity and high mortality. After an acute stroke, it is crucial to provide rapid and effective treatment to the patient. Currently, countries around the world are actively building advanced stroke centers to improve the coverage of medical services and strive to achieve the goal of establishing one stroke center every 40 kilometers. This initiative aims to shorten the "door-to-needle time" (DNT) to save patients' lives and reduce disability rates to the greatest extent possible. In emergency care, nurses first need to determine if a patient has suffered a stroke. Once a stroke is confirmed, neurology nurses must push a stroke kit containing medications and equipment to the thrombolysis room to administer intravenous thrombolysis. This process involves a series of tedious procedures. First, the patient's weight needs to be accurately measured to calculate the dosage of the thrombolytic drug based on weight and drug characteristics. Since the dosage, preparation method, and administration method of thrombolytic drugs vary, nurses are required to be proficient in the relevant information of each drug, accurately calculate the dosage, and prepare the medication. However, in emergency situations, nurses face time pressure, which can easily lead to errors in the process, such as incorrect drug dosage calculations or misremembering the calculation method, resulting in medical accidents. Furthermore, existing vital sign monitoring instruments lack the ability to interpret vital sign data specifically designed for stroke thrombolysis patients, making it impossible to accurately issue warnings for stroke thrombolysis patients. Summary of the Invention

[0003] The purpose of this invention is to provide a method, device, equipment, and storage medium for assessing stroke patients undergoing thrombolysis, which can quickly calculate the dosage of medication, avoid errors in the calculation of thrombolytic drug dosage, and accurately assess the vital signs data of thrombolytic patients, so as to detect abnormalities in a timely manner and issue early warnings.

[0004] To achieve the above objectives, this invention discloses a method for assessing stroke patients undergoing thrombolysis, comprising: Obtain patient information and retrieve corresponding weight data from the record database based on the patient information; Read the drug type and obtain the corresponding dosage coefficient and conversion factor from the drug database based on the drug type; The dosage data of the thrombolytic drug is calculated using a first formula, and the calculated dosage data is sent to the display module. The first formula is... Where W is the weight data, C is the dosage coefficient, and F is the drug conversion factor; Real-time acquisition of patient blood pressure, heart rate, and blood oxygen saturation data; The system can determine in real time whether the acquired blood pressure data, heart rate data, and blood oxygen saturation data are within a first range, a second range, and a third range, wherein the first range is 70 to 180, the second range is 50 to 110, and the third range is 90 to 100. If the determination is not correct, an alarm signal is issued. Every first time interval, the acquired blood pressure data, heart rate data, and blood oxygen saturation data are recorded to the nursing record.

[0005] Furthermore, the drug types include tenecteplase and alteplase, wherein the dose coefficient C of tenecteplase is 0.25 mg / kg, the conversion factor F of tenecteplase is 16 mg / 3 ml, the dose coefficient C of alteplase is 0.9 mg / kg, and the conversion factor F of alteplase is 1 mg / ml.

[0006] Furthermore, the first duration is 5 to 15 minutes.

[0007] Furthermore, after the step of "recording the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing record every first time interval," it also includes: Determine whether the blood pressure data, heart rate data, and blood oxygen saturation data recorded in the nursing document have reached the set number of times. If the determination is yes, then record the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing document every second time interval.

[0008] Furthermore, the set number of times is 4 to 10 times, and the second duration is 50 to 60 minutes.

[0009] Furthermore, after the step of "calculating the dosage data of the thrombolytic drug using the first formula and sending the calculated dosage data to the display module", the method further includes: Based on the type of drug being read, retrieve the corresponding drug precautions from the drug database; Based on the obtained patient information, retrieve the patient's physical condition records and medication records from the record database; Send the acquired physical condition records, medication records, and medication precautions to the display module.

[0010] To achieve the above objectives, the present invention discloses an assessment device for stroke patients undergoing thrombolysis, comprising: The first acquisition module is used to acquire patient information and retrieve corresponding weight data from the record database based on the patient information; The second acquisition module is used to read the drug type and obtain the corresponding dosage coefficient and conversion factor from the drug database based on the drug type. The calculation module is used to calculate the dosage data of the thrombolytic drug using the first formula, and send the calculated dosage data to the display module; The third acquisition module is used to acquire the patient's blood pressure data, heart rate data, and blood oxygen saturation data in real time; The judgment module is used to determine in real time whether the acquired blood pressure data, heart rate data, and blood oxygen saturation data are within the first range, the second range, and the third range respectively; The recording module is used to record the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing record every first time interval.

[0011] To achieve the above objectives, the present invention discloses an electronic device comprising: One or more processors; One or more memories are provided for storing one or more programs, which, when executed by the processor, enable the processor to implement the aforementioned method for assessing stroke patients undergoing thrombolysis.

[0012] To achieve the above objectives, the present invention discloses a computer-readable storage medium having a program stored thereon, which, when executed by a processor, implements the aforementioned method for assessing stroke patients undergoing thrombolysis.

[0013] Compared with existing technologies, this invention assists medical personnel in calculating the dosage of thrombolytic drugs and monitoring the vital signs of thrombolytic patients. First, it acquires patient information and retrieves the patient's weight data from a record database. Second, it reads the drug type and retrieves the dosage coefficient and conversion factor from the drug database. Then, it calculates the dosage data of the thrombolytic drug using a first formula and displays it on a display module, enabling rapid conversion of the drug dosage and avoiding calculation errors. Next, it acquires the patient's blood pressure, heart rate, and blood oxygen saturation data in real time and determines whether they fall within the first, second, and third ranges. If not, it issues an alarm signal, thus accurately assessing the vital signs of thrombolytic patients and promptly detecting abnormalities and issuing warnings. Attached Figure Description

[0014] Figure 1 This is a flowchart of the patient assessment method for thrombolysis after stroke, as described in an embodiment of the present invention.

[0015] Figure 2This is a block diagram of the stroke thrombolysis patient assessment device according to an embodiment of the present invention.

[0016] Figure 3 This is a system diagram of an electronic device according to an embodiment of the present invention. Detailed Implementation

[0017] To illustrate the technical content, structural features, objectives, and effects of the present invention in detail, the following description is provided in conjunction with the embodiments and accompanying drawings.

[0018] Example 1 Please see Figure 1 As shown in the figure, this invention discloses a method for assessing stroke patients undergoing thrombolysis, which includes: 101. Obtain patient information and retrieve corresponding weight data from the record database based on the patient information; It should be noted that the Hospital Information System (HIS) has a record database and a medication database. Medical staff can enter patient data into the HIS through a medical handheld terminal. This data includes the patient's number (outpatient number / inpatient number), name, age, weight, gender, physical condition records, and medication records. The HIS will save the entered patient data to the record database.

[0019] It is understood that the medical handheld terminal is responsible for implementing the assessment method for stroke thrombolysis patients. Specifically, in this embodiment, the patient information is the patient's number, but it is not limited to this. When medical staff enter the number into the medical handheld terminal, the medical handheld terminal obtains the patient data in the record database through the medical signal system and extracts the weight data from it for subsequent calculations.

[0020] 102. Read the drug type and retrieve the corresponding dosage coefficient and conversion factor from the drug database based on the drug type; Furthermore, the drug types include tenecteplase and alteplase. The dose factor C of tenecteplase is 0.25 mg / kg, and the conversion factor F of tenecteplase is 16 mg / 3 ml. The dose factor C of alteplase is 0.9 mg / kg, and the conversion factor F of alteplase is 1 mg / ml.

[0021] It should be noted that tenecteplase drug requires 3ml of sterile water for injection to dissolve one bottle of 16mg tenecteplase lyophilized powder, while alteplase drug is obtained from a 50mg / 50ml premixed infusion bag or a standard concentration vial. The above drug data are obtained by dissolving the above data in a drug database for use by medical handheld terminals when needed, but not limited to this.

[0022] It is understandable that there are two types of thrombolytic drugs, namely tenecteplase and alteplase. The choice of which drug to use for stroke patients requires confirmation and selection by medical staff. The type of drug (tenecteplase or alteplase) is selected by the patient through a medical handheld terminal. The medical handheld terminal obtains the dose coefficient C and conversion factor F of tenecteplase or alteplase from the drug database through the medical signal system, so as to calculate the dose data of the thrombolytic drug in combination with the weight data extracted in step S101.

[0023] 103. Calculate the dosage data of the thrombolytic drug using the first formula, and send the calculated dosage data to the display module. The first formula is: Where W is body weight data, C is the dose coefficient, and F is the drug conversion factor; Understandably, the medical handheld terminal is equipped with a display module. The dosage data calculated according to the first formula is displayed through the display module so that medical staff can administer medication to patients based on the displayed dosage data. For example, when a patient weighs 56kg, if tenecteplase is chosen, the dosage data of the thrombolytic drug calculated according to the first formula is D=56×0.25÷16×3=2.625ml. If alteplase is chosen, the dosage data of the thrombolytic drug calculated according to the first formula is D=56×0.9=50.4ml, but this is not a limitation.

[0024] Furthermore, after "calculating the dosage data of the thrombolytic drug using the first formula and sending the calculated dosage data to the display module," it also includes: 1031. Retrieve the corresponding drug precautions from the drug database based on the type of drug read; 1032. Based on the obtained patient information, retrieve the patient's physical condition records and medication records from the record database; 1033. Send the acquired physical condition records, medication records, and medication precautions to the display module.

[0025] It should be noted that in this embodiment, steps 1031 to 1033 and steps 104 to 106 are executed synchronously after step 103 is completed, but this is not a limitation.

[0026] Understandably, the patient's medical history includes abnormal liver function, kidney insufficiency, and bleeding tendency; medication records include anticoagulants, antiplatelet drugs, antibiotics with anticoagulant or antiplatelet effects, and traditional Chinese medicine; medication precautions include single intravenous bolus injection for tenecteplase, multi-stage intravenous infusion for alteplase, avoiding puncture within 24 hours, and monitoring bleeding risk. The medical handheld terminal displays these precautions via a display module to guide medical staff in performing correct medical procedures. It also displays the patient's medical history and medication records, facilitating the assessment of bleeding risk and determining the safety risk level after thrombolytic therapy. This helps optimize subsequent treatment plans and improve medication safety.

[0027] 104. Real-time acquisition of patient blood pressure, heart rate, and blood oxygen saturation data; It should be noted that, in this embodiment, the blood pressure data (BP) is obtained through an electronic blood pressure monitor, the heart rate data (HR) is obtained through an electrocardiogram (ECG) monitor, and the blood oxygen saturation data (SPO2) is obtained through a pulse oximeter clip. The medical handheld terminal is equipped with a wireless communication module and is connected to the aforementioned electronic blood pressure monitor, ECG monitor, and pulse oximeter clip to obtain the patient's blood pressure data, heart rate data, and blood oxygen saturation data detected by the electronic blood pressure monitor, ECG monitor, and pulse oximeter clip in real time, but is not limited to these.

[0028] 105. Real-time determination of whether the acquired blood pressure data, heart rate data and blood oxygen saturation data are within the first range, second range and third range respectively, wherein the first range is 70 to 180, the second range is 50 to 110 and the third range is 90 to 100. If the determination is not correct, an alarm signal is issued. Understandably, the medical handheld terminal is equipped with an alert module, which includes an indicator light, a vibration motor, and a speaker. When any of the blood pressure, heart rate, or blood oxygen saturation data collected by the medical handheld terminal through the wireless communication module is outside the corresponding data range, it indicates that the patient's vital signs are abnormal. In this case, the medical handheld terminal will alert medical staff by illuminating the indicator light, vibrating the terminal, or broadcasting a message through the speaker. This enables continuous monitoring, accurate assessment, and immediate feedback of the vital signs of thrombolysis patients, effectively improving the clinical response speed of medical staff.

[0029] 106. Record the acquired blood pressure, heart rate, and blood oxygen saturation data to the nursing record every first hour.

[0030] Furthermore, the first duration is 5 to 15 minutes.

[0031] Furthermore, after stating that "the acquired blood pressure, heart rate, and blood oxygen saturation data will be recorded to the nursing documentation every first hour," it also includes: 107. Determine whether the blood pressure, heart rate, and blood oxygen saturation data recorded in the nursing document have reached the set number of times. If the determination is yes, record the acquired blood pressure, heart rate, and blood oxygen saturation data in the nursing document every second time interval.

[0032] Furthermore, the number of times is set to 4 to 10, and the second duration is 50 to 60 minutes.

[0033] It should be noted that in this embodiment, the first duration is set to 10 minutes, the number of times is set to 6, and the second duration is set to 60 minutes. That is, in the first hour, the patient's blood pressure, heart rate and blood oxygen saturation data are recorded in the nursing record every ten minutes, and after one hour, the patient's vital signs data are recorded once every hour to ensure the timeliness and accuracy of the vital signs data recording. The nursing record will be uploaded to the hospital information system's record database to provide important support for subsequent treatment effect evaluation. Compared with existing technologies, this invention assists medical personnel in calculating the dosage of thrombolytic drugs and monitoring the vital signs of thrombolytic patients. First, it acquires patient information and retrieves the patient's weight data from a record database. Second, it reads the drug type and retrieves the dosage coefficient and conversion factor from the drug database. Then, it calculates the dosage data of the thrombolytic drug using a first formula and displays it on a display module, enabling rapid conversion of the drug dosage and avoiding calculation errors. Next, it acquires the patient's blood pressure, heart rate, and blood oxygen saturation data in real time and determines whether they fall within the first, second, and third ranges. If not, it issues an alarm signal, thus accurately assessing the vital signs of thrombolytic patients and promptly detecting abnormalities and issuing warnings.

[0034] Example 2 Please see Figure 1 and Figure 2 This invention discloses an assessment device for stroke patients undergoing thrombolysis, comprising: The first acquisition module 201 is used to acquire patient information and retrieve corresponding weight data from the record database based on the patient information. The second acquisition module 202 is used to read the drug type and obtain the corresponding dosage coefficient and conversion factor from the drug database based on the drug type; The calculation module 203 is used to calculate the dosage data of the thrombolytic drug using the first formula, and send the calculated dosage data to the display module; The third acquisition module 204 is used to acquire the patient's blood pressure data, heart rate data, and blood oxygen saturation data in real time. The judgment module 205 is used to judge in real time whether the acquired blood pressure data, heart rate data and blood oxygen saturation data are within the first range, the second range and the third range respectively; The recording module 206 is used to record the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing record every first time interval.

[0035] Example 3 Please see Figure 1 and Figure 3 This invention discloses an electronic device comprising: One or more processors 301; One or more memories 302 are used to store one or more programs, which, when executed by a processor, enable the processor to implement the aforementioned assessment method for stroke thrombolysis patients.

[0036] Example 4 This application discloses a computer-readable storage medium storing a program thereon, which, when executed by a processor, implements the aforementioned method for assessing stroke patients undergoing thrombolysis.

[0037] Example 5 This application discloses a computer program product or computer program, which includes computer instructions stored in a computer-readable storage medium. A processor of an electronic device reads the computer instructions from the computer-readable storage medium and executes the computer instructions, causing the electronic device to perform the aforementioned method for assessing stroke patients undergoing thrombolysis.

[0038] It should be understood that, in the embodiments of this application, the processor may be a central processing unit (CPU), but it may also be other general-purpose processors, digital signal processors (DSPs), application-specific integrated circuits (ASICs), field-programmable gate arrays (FPGAs), or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc. A general-purpose processor may be a microprocessor or any conventional processor.

[0039] Those skilled in the art will understand that all or part of the processes in the above embodiments can be implemented by hardware related to computer program instructions. The program can be stored in a computer-readable storage medium, and when executed, it can include the processes of the embodiments of the above methods. The storage medium can be a magnetic disk, optical disk, read-only memory (ROM), or random access memory (RAM), etc.

[0040] The above-disclosed embodiments are merely preferred embodiments of the present invention and should not be construed as limiting the scope of the present invention. Therefore, any equivalent variations made in accordance with the claims of the present invention are still within the scope of the present invention.

Claims

1. A method for assessing stroke patients undergoing thrombolysis, characterized in that, include: Obtain patient information and retrieve corresponding weight data from the record database based on the patient information; Read the drug type and obtain the corresponding dosage coefficient and conversion factor from the drug database based on the drug type; The dosage data of the thrombolytic drug is calculated using a first formula, and the calculated dosage data is sent to the display module. The first formula is... Where W is the weight data, C is the dosage coefficient, and F is the drug conversion factor; Real-time acquisition of patient blood pressure, heart rate, and blood oxygen saturation data; The system can determine in real time whether the acquired blood pressure data, heart rate data, and blood oxygen saturation data are within a first range, a second range, and a third range, wherein the first range is 70 to 180, the second range is 50 to 110, and the third range is 90 to 100. If the determination is not correct, an alarm signal is issued. Every first time interval, the acquired blood pressure data, heart rate data, and blood oxygen saturation data are recorded to the nursing record.

2. The method for assessing stroke patients undergoing thrombolysis according to claim 1, characterized in that, The drug types include tenecteplase and alteplase. The dose factor C of tenecteplase is 0.25 mg / kg, and the conversion factor F of tenecteplase is 16 mg / 3 ml. The dose factor C of alteplase is 0.9 mg / kg, and the conversion factor F of alteplase is 1 mg / ml.

3. The method for assessing stroke patients undergoing thrombolysis according to claim 1, characterized in that, The first duration is 5 to 15 minutes.

4. The method for assessing stroke patients undergoing thrombolysis according to claim 1, characterized in that, Following the statement "recording the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing record every first time interval", the document also includes: Determine whether the blood pressure data, heart rate data, and blood oxygen saturation data recorded in the nursing document have reached the set number of times. If the determination is yes, then record the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing document every second time interval.

5. The method for assessing stroke patients undergoing thrombolysis according to claim 4, characterized in that, The set number of times is 4 to 10 times, and the second duration is 50 to 60 minutes.

6. The method for assessing stroke patients undergoing thrombolysis according to claim 1, characterized in that, After the step of "calculating the dosage data of the thrombolytic drug using the first formula and sending the calculated dosage data to the display module", the method further includes: Based on the type of drug being read, retrieve the corresponding drug precautions from the drug database; Based on the obtained patient information, retrieve the patient's physical condition records and medication records from the record database; Send the acquired physical condition records, medication records, and medication precautions to the display module.

7. A device for assessing stroke patients undergoing thrombolysis, characterized in that, include: The first acquisition module is used to acquire patient information and retrieve corresponding weight data from the record database based on the patient information; The second acquisition module is used to read the drug type and obtain the corresponding dosage coefficient and conversion factor from the drug database based on the drug type. The calculation module is used to calculate the dosage data of the thrombolytic drug using the first formula, and send the calculated dosage data to the display module; The third acquisition module is used to acquire the patient's blood pressure data, heart rate data, and blood oxygen saturation data in real time; The judgment module is used to determine in real time whether the acquired blood pressure data, heart rate data, and blood oxygen saturation data are within the first range, the second range, and the third range respectively; The recording module is used to record the acquired blood pressure data, heart rate data, and blood oxygen saturation data to the nursing record every first time interval.

8. An electronic device, characterized in that, include: One or more processors; One or more memories for storing one or more programs, which, when executed by the processor, cause the processor to implement the stroke thrombolysis patient assessment method as described in any one of claims 1 to 6.

9. A computer-readable storage medium having a program stored thereon, characterized in that, When the program is executed by the processor, it implements the stroke thrombolysis patient assessment method as described in any one of claims 1 to 6.

Images